Oncology and Hematology

641-650 of 650

• 

  RestartResume

  Genetic Research into Hypodiploid ALL

  RestartResume

  Genetic Research into Hypodiploid ALL

  Focus on Cancer

  Genetic Research into Hypodiploid ALL

  Bruce Bloom, DDS, JD; Charles Mullighan, MBBS, MSc, MD

  • 

    

    Bruce Bloom, DDS, JD

  • 

    

    Charles Mullighan, MBBS, MSc, MD

• 

  RestartResume

  An Emerging Vaccine Helps Prevent Prostate Cancer

  RestartResume

  An Emerging Vaccine Helps Prevent Prostate Cancer

  Clinician's Roundtable

  An Emerging Vaccine Helps Prevent Prostate Cancer

  Maurice Pickard, MD; James L. Gulley, MD, PhD, FACP

  • 

    

    Maurice Pickard, MD

  • 

    

    James L. Gulley, MD, PhD, FACP

• 

  RestartResume

  Helping Cancer Patients with Quality of Life Issues Post Hysterectomy

  RestartResume

  Helping Cancer Patients with Quality of Life Issues Post Hysterectomy

  Clinician's Roundtable

  Helping Cancer Patients with Quality of Life Issues Post Hysterectomy

  Leslie P. Lundt, MD; Lori Brotto, PhD

  • 

    

    Leslie P. Lundt, MD

  • 

    

    Lori Brotto, PhD

• 

  RestartResume

  Using Testosterone for Refractory Prostate Cancer

  RestartResume

  Using Testosterone for Refractory Prostate Cancer

  Clinician's Roundtable

  Using Testosterone for Refractory Prostate Cancer

  Bruce Bloom, DDS, JD; Walter Stadler, MD

  • 

    

    Bruce Bloom, DDS, JD

  • 

    

    Walter Stadler, MD

• 

  RestartResume

  Improving the Prognoses of Multiple Myeloma

  RestartResume

  Improving the Prognoses of Multiple Myeloma

  Clinician's Roundtable

  Improving the Prognoses of Multiple Myeloma

  Mark Nolan Hill, MD; James Berenson, MD

  • 

    

    Mark Nolan Hill, MD

  • 

    

    James Berenson, MD

• 

  RestartResume

  Multiple Myeloma: Current Treatment Modalities

  RestartResume

  Multiple Myeloma: Current Treatment Modalities

  Clinician's Roundtable

  Multiple Myeloma: Current Treatment Modalities

  Mark Nolan Hill, MD; James Berenson, MD

  • 

    

    Mark Nolan Hill, MD

  • 

    

    James Berenson, MD

• 

  RestartResume

  Prostate Cancer Predictability: Can We Anticipate a Patient's Risk in 25 Years?

  RestartResume

  Prostate Cancer Predictability: Can We Anticipate a Patient's Risk in 25 Years?

  Clinician's Roundtable

  Prostate Cancer Predictability: Can We Anticipate a Patient's Risk in 25 Years?

  Bill Rutenberg, MD; Andrew Vickers, PhD

  • 

    

    Bill Rutenberg, MD

  • 

    

    Andrew Vickers, PhD

• 

  RestartResume

  The Environmental Etiologies of Multiple Myeloma

  RestartResume

  The Environmental Etiologies of Multiple Myeloma

  Clinician's Roundtable

  The Environmental Etiologies of Multiple Myeloma

  Shira Johnson, MD; Brian Durie, MD

  • 

    

    Shira Johnson, MD

  • 

    

    Brian Durie, MD

• 

  RestartResume

  New Treatments for Multiple Myeloma

  RestartResume

  New Treatments for Multiple Myeloma

  Clinician's Roundtable

  New Treatments for Multiple Myeloma

  Shira Johnson, MD; Brian Durie, MD

  • 

    

    Shira Johnson, MD

  • 

    

    Brian Durie, MD

• 

  RestartResume

  Endometrial Cancer

  RestartResume

  Endometrial Cancer

  Clinician's Roundtable

  Endometrial Cancer

  Joel Heller, MD; Diljeet Singh, MD

  • 

    

    Joel Heller, MD

  • 

    

    Diljeet Singh, MD

• Previous
• 1
• 2
• …
• 39
• 40
• 41
• Next